Embody, Inc. — Department of Defense SBIR Phase I: AF211-CSO1
Embody, Inc. — SBIR Phase I award from Department of Defense.
- Amount
- $49,768
- Agency
- Department of Defense · Air Force
- Program / Phase
- SBIR · Phase I
- Topic
- AF211-CSO1
- Solicitation
- X21.1
- NAICS
- —
- Place of performance
- VA
- Period
- 2021-04-14 → 2021-07-19
Description
Embody, Inc. has pioneered a breakthrough, scalable, additive biomanufacturing approach of hybrid electrospinning/pneumatospinning to engineer a collagen-based construct designed to promote new, highly aligned tendon-like tissue growth at the tendon implant site. This means the TAPESTRYTM helps the patient’s body to promote soft tissue healing and will be completely absorbed during the remodeling process. The result is improved healing by the patient’s own cells—no implant remains. Unlike traditional materials in competitor’s products, TAPESTRY’s bioengineering is based on the tendon it is going to be repairing and the implant will mimic the structure of the patient’s native tissue to accelerate repair. Embody, Inc.’s revolutionary bioengineered tendon analog known as TAPESTRYTM should be the Air Force’s go-to for advanced regenerative tendon repair.